Reduced-Dose Paclitaxel Balloon Ups Femoral 2-Year Patency Reduced-Dose Paclitaxel Balloon Ups Femoral 2-Year Patency

ILLUMENATE EU RCT suggests that great patency rates using a balloon coated with paclitaxel at below-standard concentrations are durable, but comparing drug-coated balloons remains a challenge.Medscape Medical News

Source: Medscape Medical News Headlines - December 5, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news